He has had a long-standing interest in new devices and new pharmacologic agents for percutaneous coronary and cardiac intervention, as well as quality improvement in the catheterization laboratory.

Research: New devices and drugs for coronary intervention. Percutaneous treatment of Hypertrophic, Obstructive Cardiomyopathy, Quality Assurance in the cardiac catheterization laboratory

Clinical Interests:

  • Interventional Cardiology
  • Consultative Cardiology

Dr. Breall has an interest in and an extensive history of involvement with multi-center clinical trials involving new devices and drugs to potentially help patients in the cardiac catheterization suite. He has been the principle site investigator for over 30 studies.

Cardiovascular Medicine
MD, Yeshiva University, 1987
PhD, University of California, San Francisco, Physiology, 1983
BA, University of California, Berkeley, Physiology, 1978